You are in browse mode. You must login to use MEMORY

level: Level 2

Questions and Answers List

level questions: Level 2

Question	Answer
AIM of Pharmacoepidemiology 1 WHO targets its pharmacoepidemiological efforts to ensure the __ of drugs. 2 The studies focus on	. 1 quality, safety and efficacy 2 ― Global trends in prescribing ― Appropriateness of drug use ― Medication adherence ― Lifestyle effects on drug therapy ― Special population (Elderly, Pediatric, etc.) drug therapy ― Drug Interactions ― Predictable ADRs ― Uncommon and unpredictable ADRs
The sources of drug data includes:	―Institutionalized medical records and databases from hospital and pharmacy claims. ―System wide databases from health insurance claims or pharmaceutical organization. ―National databases like Medical Expenditure Panel Survey, National Ambulatory Medical Care Survey. ―Field data like records from dispensers, sellers or distributers or from small groups. ―Experimental clinical trial data.
is defined as the identification and collection of information regarding drugs after their approval for use in a population. a method of systematically monitoring the safety and effectiveness of new drugs in the real world using a variety of patient types with many different comorbid diseases. Cornerstone of Pharmacoepidemiology __ data demonstrate whether a patient has been exposed to the drug, and adverse health effects that required a health care interaction.	Postmarketing surveillance (PMS)
Application of Pharmacoepidemiology	1 Government agencies & Health care plans: 2 Practitioners 3 Pharmaceutical industries 4 Academicians 5 Attorneys 6 Consumers and Patients
1 Practicing pharmacist is in a __ to help identify issues or problems that a pharmacoepidemiologist may want to study further. Ex. identifying and reporting adverse drug events, which can then be studied using pharmacoepidemiology techniques. 2 __ should be USERS OF PHARMACOEPIDEMIOLOGY RESEARCH FINDINGS. Ex. making drug therapy choices and making formulary	1 prime position 2 Pharmacists and public health practitioners